1B-1D) [5] . Wnt signaling in early Xenopus blastulas activates dorsal regulators, including siamois and Xnr3. Treating the embryos for 5-10 min with 300 mM lithium is known to inhibit GSK3b [6] , stabilize b-catenin [7] , and dorsalize the embryos ( Figures 1B and 1C ) [8, 9] . We observed, however, that embryos treated with moderate doses of lithium (150 and 200 mM) largely retained a wild-type level of siamois and Xnr3 expression (Figure 1C , see red arrows) and developed into wild-type tailbuds ( Figure 1B ). More strikingly, despite an absence of marked phenotypic effects, the embryos showed increased b-catenin level ( Figure 1D , see red arrows). A similar lack of embryo phenotypes despite increased b-catenin level was observed with other perturbations to the Wnt pathway, including injection of Axin1 and GBP mRNA. This led us to assay the TopFlash reporter, a commonly used reporter of Wnt signaling driven by a tandem repeat of Wnt-responsive elements (WREs), to test whether the increased b-catenin was transcriptionally active. Indeed, the TopFlash reporter also showed increased activity at moderate doses of lithium ( Figure 1D , red arrows). Therefore, even though the TopFlash reporter faithfully tracked the rise of b-catenin level, the contrasting wild-type expressions of the endogenous genes suggest a missing mechanism beyond WRE. It is notable that b-catenin itself, as a central regulator in the pathway, did not correlate with the target gene expression but tracked the extent of the perturbations, hinting at a possible role for b-catenin in the missing regulation.
An 11-bp Negative Regulatory Element Is Necessary for Dorsal Specification of siamois
To locate the missing regulation, we focused on siamois [9] [10] [11] . Three WREs are found within 500 bp upstream of siamois and are necessary for siamois activation (Figure 2A ) [10, 11] . We built a luciferase reporter using a 3-kb fragment of siamois promoter (pSia). We confirmed that 3-kb pSia-luc mimics the temporal expression of siamois, beginning at mid-stage 8 and reaching steady state by stage 10. Reported here is the luciferase expression at early stage 10, reliably identified by the onset of dorsal lip formation.
We perturbed the GSK3b activity in a dose-response manner as described earlier. We found that the 3-kb promoter recapitulated the endogenous siamois response, preserving wild-type expression at 150 mM LiCl ( Figure 2B ). By contrast, an 848-bp fragment of siamois promoter that still contains the three WREs responded readily to perturbations ( Figure 2C ). To examine the spatial regulation of these promoter fragments, we tested lacZ reporters. Indeed, even though 3-kb and 848-bp lacZ retained dorsal expression, the 848-bp fragment showed expanded expression ( Figures 2C and 2D , inset). The missing regulation in the 848-bp fragment was especially revealed when a moderate lithium dose was applied: the 3-kb pSia-lacZ preserved dorsal expression at 150 mM LiCl, whereas the 848-bp pSia-lacZ readily expanded.
Therefore, a suppressive, distal element located between 848 bp and 3 kb is necessary for the dorsal specification of pSia expression. Using the differential response at 150 mM lithium as a readout, we performed a promoter bashing screen to locate the element. Halving to 1.3 kb preserved wild-type reporter expression, as did further truncations up until 963 bp (Figures 2D and 2F ). Loss of suppression at 150 mM LiCl was finally observed with truncation to 952 bp and with subsequent shorter constructs ( Figures 2E and 2F ). This analysis identified a suppressive element at 1 kb upstream of siamois, with most activity centered on 11 bp between 963 and 952 bp ( Figure 2G ).
The 11-bp negative regulatory element (11-bp NRE) is AT-rich (5 0 -CTG TTA TTT AA-3 0 ). To further characterize the 11-bp NRE, we performed a mutagenesis analysis. With the 1.3-kb promoter fragment, we mutated the 11-bp NRE one base at a time (i.e., purine into pyrimidine or vice versa). We found that the majority of single-base alterations affected the response, with the largest effect produced by a single-base mutation on the 11 th nucleotide, which recapitulated the effect of deletion of the 11-bp NRE (Figure 2H) . Finally, the 11-bp NRE is sufficient to recapitulate the suppression. Inserting the 11-bp NRE into the 848-bp promoter ( Figure 2F ) rescued the wild-type expression. The same effect was observed when the 11-bp NRE was pasted into even shorter promoters ( Figure S1 ). These results suggest that regulation of siamois not only requires WREs but also a suppressive 11-bp NRE.
The 11-bp NRE Interacts with Tcf Next, we set out to find the factors that bind to the 11-bp NRE using electrophoretic mobility shift assay (EMSA) (Figures 3A and 3B). As the protein source, we used the high-speed supernatant of Xenopus egg extracts. We reasoned that the binding factor(s) must be maternal, as Wnt signaling begins in early blastula before zygotic transcription [12, 13] . As the DNA probe, we synthesized a 30-bp double-stranded oligomer containing the 11-bp NRE, flanked by the endogenous sequence. As a control for the probe, we used the strongest mutant with an A/C switch at the 11 th nucleotide (m11 mutant; Figure 2H ).
We observed specific binding to the 11-bp NRE in the EMSA ( Figure 3C ). The band was competed away when excess, unlabeled DNA probe was added ( Figure 3C, lanes 3 and 4) . The band was competed away much less effectively when excess, unlabeled m11 mutant probe was used ( Figure 3C , compare lanes indicated by blue arrows). The specific band was reproducible across batches of extracts, despite variation in non-specific binding patterns and the amount of competitors needed ( Figure 3C ).
Having the specific EMSA activity, we proceeded to identify the binding factor(s) by testing some known transcription factors. Lacking good antibodies to these factors in Xenopus, we tested whether the DNA-binding sites of the factors would compete with the EMSA band. Binding sites of various transcription factors, e.g., CREB, p53, nuclear factor kB (NF-kB), and AP-1, failed to compete significantly ( Figure S2A ). Unexpectedly, the one DNA fragment that competed away the EMSA band was the WRE itself ( Figure 3D ). The specific band was competed away when excess, unlabeled WRE probe was added ( Figure 3D , lanes 5 and 6)-to a similar extent as it was competed away by excess, unlabeled wildtype probe ( Figure 3C, lanes 3 and 4) . By contrast, a negative control probe, carrying two mutations that destroy binding of the Tcf protein (i.e., FopFlash construct) [14] , competed much less effectively ( Figure 3D , lanes 7 and 8, see blue arrows).
The competition by WRE suggests that Tcf proteins bind to the 11-bp NRE. Indeed, XTcf3 antibodies, raised against an N-terminal (XTcf3n) and C-terminal fragment (XTcf3c) [15] , competed away the specific band ( Figure 3E ). These results suggest that a Tcf/Lef protein binds the 11-bp NRE and that XTcf3 is the predominant binder in our in vitro assay.
The 11-bp NRE Interacts with b-Catenin
The binding of Tcf protein to the 11-bp NRE raises questions on the binding partner, as Tcf does not usually act alone [4] . The binding of Tcf to the 11-bp NRE is also interesting in light of our earlier findings ( Figure 1 ) that b-catenin intriguingly tracks the extent of perturbations, motivating us to test the roles of b-catenin.
We found that adding polyclonal b-catenin antibody to the EMSA reaction produced a strong supershift and a weak downshift smear ( Figure 3F ). To further confirm the binding of b-catenin, we performed a binding assay using purified recombinant Xenopus b-catenin and Tcf3 ( Figure S2B ). As expected, Tcf3 alone produces a smear signal, suggesting an unstable binding. A strong, sharp band was observed in the presence of both Tcf3 and b-catenin.
To test whether b-catenin acts on the 11-bp NRE in the siamois promoter in vivo, we performed chromatin immunoprecipitation in the embryos ( Figure 3G ). We collected embryos at stage 10, when siamois expression is at peak. We observed a strong signal indicating b-catenin binding in the 11-bp region. In the same experiment, as expected, b-catenin binding was also detected from the WRE region in the siamois promoter. As a negative control, negligible signal was detected with IgG antibody and from siamois-or ODC-coding regions. These results suggest that the 11-bp NRE, required for siamois regulation, interacts with b-catenin and Tcf.
The 11-bp NRE Is Present in the Promoter of More Target Genes Beyond siamois, might the 11-bp NRE regulate other Wnt target genes? At first, we found no results looking for the exact 11-bp sequence in other Xenopus targets. However, examining the siamois promoter closely, we identified two sites with a sequence pattern similar to that of the 11-bp NRE ( Figures 4A  and 4B ), a G/C cap, followed by eight A/Ts-with an occasional C/G in the fifth position. All 11-bp-like elements competed with the WRE ( Figure S3A ). Hence, three 11-bp NREs are present in the siamois promoter, although losing the distal one is sufficient to disrupt the suppression. Following this lead, we searched for a similar sequence pattern in other known direct Wnt targets in Xenopus. We found candidate 11-bp NREs in the promoter of Xnr3 and engrailed ( Figure 4B ). The predicted 11-bp NREs in Xnr3 and engrailed produced a specific EMSA band, which was shifted by polyclonal b-catenin antibody ( Figure S3B ).
The 11-bp NRE Regulates Brachyury Expression in Mouse Embryonic Stem Cells
With the predictive sequence pattern ( Figure 4C ), we investigated whether 11-bp NRE is present in mammals. We examined promoters of known direct Wnt targets in mouse embryonic stem cells (mESCs). We identified several candidates, including some in the promoters of well-characterized Wnt targets, such as Brachyury (T), Axin2, and Cdx4 ( Figure 4B ). EMSA assay confirmed that these 11-bp NREs produced a specific band that was shifted by b-catenin antibody ( Figure S3C ).
To test whether the 11-bp NREs function in the regulation of mammalian Wnt targets, we examined T regulation. T promoter has two WRE sites, at 191 and 273 bp upstream of the transcription start site ( Figure 4D ) [16] . T is an early marker of mesoderm differentiation. Basal expression of T, present in a fraction of the stem cell population [17] , is activated by endogenous secretion of Wnt proteins [18] and marks the early mesoderm-committed (EM) progenitors [17] .
We identified two candidate 11-bp NREs, at 999 and 1,613 bp upstream of the transcription start site ( Figure 4D ). To test whether the 11-bp NREs interact with b-catenin in vivo, we performed chromatin immunoprecipitation using b-catenin antibody. We observed signal from the proximal 11-bp NRE expressing renilla luciferase was co-injected, and the pSia-driven firefly luciferase signal was measured relative to the renilla luciferase signal. In all of the plots shown here, the luciferase/renilla signal is normalized to that in the control, untreated embryos. Data are presented as mean ± SEM from three to five biological replicates. Error bars not visible have negligible SEM. ( Figure 4E ). As a positive control, strong signal was also observed from the À273-bp WRE ( Figure 4E ). As negative controls, almost 10-fold lower signal was observed using mouse IgG antibody and negligible signal from the exon 2 region of T. We observed much lower signal from the distal NRE, suggesting the proximal one as the dominant NRE in the T promoter.
To test the roles of the 11-bp NREs in T regulation, we used CRISPR/Cas9 to delete the 11-bp NREs from the endogenous promoter of T. Four sequence-verified TD11bp clones were then assayed for T expression by qRT-PCR. We observed that TD11bp clones showed significantly higher expression levels of T than the wild-type cells ( Figure 4F ), suggesting increased EM progenitors. As a control, four wild-type clones that underwent blank transfection and clonal selection showed no significant change of T expression. These results suggest that balanced regulation of T in mESCs requires 11-bp NREs as well as the WREs.
The 11-bp NRE Is Prevalent in b-Catenin Chromatin Immunoprecipitation Sequencing in Human Cells
Finally, equipped with the criterion of 11-bp NRE gathered across several Wnt direct targets ( Figure 4C ) and one confirmed with binding and functional assays (Figures 2, 3, 4E , and 4F), we asked whether 11-bp NREs are present more widely across Wnt target genes. To address this question, we analyzed b-catenin chromatin immunoprecipitation sequencing (ChIP-seq) datasets from human cells [19, 20] . We found significant enrichment of 11-bp NREs in b-catenin peaks from HEK293T (p value = 2.58 eÀ31) and HCT116 cells (p value = 4.24eÀ12). Multiple 11-bp NREs were often predicted within the b-catenin-bound fragments. We found significant co-localization of 11-bp NREs with the WRE: of the 2,818 b-catenin peaks that contain a WRE, 71% also contain 11-bp NREs in in HEK293T cells ( Figure 4G ) and 45% do so in HCT116 cells ( Figure S4 ). Our analysis also indicates a significant fraction of b-catenin-bound fragments that contains 11-bp NREs only (Figure 4G ), suggesting that the 11-bp NRE may have more functions beyond what we found here.
DISCUSSION
We found an 11-bp NRE that b-catenin and Tcf act on in the promoters of many Wnt target genes. The 11-bp NRE is necessary for siamois regulation in Xenopus embryos and Brachyury regulation in mESCs. Our study suggests a new model of gene regulation in the Wnt pathway, where signal in the pathway not only activates (E) ChIP using b-catenin antibody, followed by PCR amplification from 11-bp NRE (left) and WRE region (right) in the T promoter. The result was reproducible across two biological replicates. To ensure that immunoprecipitation of the 11-bp NRE fragments was not confounded by the WRE, we sonicated the chromatin to 100-300 bp and performed PCR validation. (F) CRISPR/Cas9 was used to target genomic deletion of the 11-bp NREs in the T promoter. Four mESC clones carrying genomic deletion of 11-bp NREs (TD11bp) were analyzed with qRT-PCR for T expression. Error bars indicate SD from three biological replicates. (G) Analysis of b-catenin ChIP-seq on HEK293T cells. We examined 1-kb b-catenin peak regions for the presence of the 11-bp NRE and WRE. Of the 4,484 total peaks from the b-catenin ChIP-seq, 3,748 contain the 11-bp NRE and/or WRE motifs. Of these 3,748 peaks, 2,008 contain both motifs. See also Figure S4 . (H) Our findings suggest that signal in the Wnt pathway does not only activate target genes through WRE, but also tunes expression of the gene through a suppressive 11-bp NRE. Further, our findings also suggest that b-catenin mediates this coupling.
target genes through the WRE but also, in some contexts, tunes expression of the genes through a distinct 11-bp NRE ( Figure 4I ). Interestingly, although multiple NREs are present in siamois and T promoter, there seems to be a dominant one that mediates suppression. The ChIP data in T promoter suggests that the other NRE binds less strongly to b-catenin and, therefore, may play subtler roles. In Drosophila, it was found that Wnt signaling represses Ugt36Bc and TiG genes through a WGAWAW site that binds to b-catenin [21] . Our finding identifies a distinct repressive site in vertebrates and one that implicates a different role for b-catenin, where it acts in an opposite manner in the same promoter, as an activator through the WRE and a suppressor through the 11-bp NRE. With regard to Tcf, our finding can be consistent with models in the field, where the same or distinct Tcf proteins may specialize as an activator or a repressor [4] .
A circuit where the input activates the output and at the same time suppressively tunes the output is known in engineering as the incoherent feedforward loop (IFFL). Such a circuit has been found in transcriptional networks of bacteria, yeast, and human cells [22] [23] [24] [25] . While these analyses focused on protein-protein interactions, an interesting aspect of the IFFL we found in the Wnt pathway is its implementation through multiple cis elements. We know of one other instance where a regulator works through multiple cis elements in an IFFL mode, in the regulation of porin OmpF in E. coli [26] .
More generally, IFFL belongs to a class of recurring strategy in biological systems, where a biological molecule is used in a paradoxical manner [27] . Paradoxical circuits, and the incoherent feedforward circuit specifically, moreover, are versatile circuits. By tuning the relative strengths and timescales of the activation and repression arm, an incoherent feedforward circuit can generate a sustained net activation-but beyond that, also a net repression, a temporal pulse, response acceleration, band-pass filtering, and fold change detection (see Methods S1, as well as [28] [29] [30] [31] [32] [33] [34] ). Moreover, inclusion of an IFFL downstream of the Wnt pathway can explain how the endogenous gene response remains wild-type despite perturbations, either by acting as an amplitude filter (if the timescales of activation and repression are similar) or fold change detector (if the repression is slow and strong) (Methods S1). Although it is difficult presently to estimate the relative affinities of the two sites, an extract system combined with sophisticated methods such as surface plasmon resonance (SPR) could be a next approach. It would also be interesting to investigate whether different co-factors or chromatin modifiers are recruited by b-catenin to the 11-bp NRE. In conclusion, the finding of the 11-bp NRE not only suggests a different model of gene regulation in the Wnt pathway and one that implicates a function for b-catenin as a feedforward sensor, but also provides a plausible mechanism by which gene regulation by b-catenin and Tcf can generate more versatile dynamics across contexts.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Xenopus laevis Experiment protocols were approved by the Institutional Animal Care and Use Committees and performed in accordance with NIH guidelines. Female and male mature pigmented Xenopus laevis were obtained from Nasco (female LM00535MX, male: LM00715MX). The Xenopus is housed in an aquarium system (Aquannering) equipped with UV light, with automated control of conductivity, pH, and temperature. The animals are daily fed with Nasco frog brittle (Nasco cat# SA05961(LM)MX). Female frogs rested for 3-4 months between egg collection. Male frogs were euthanized for testis dissection.
Mouse embryonic stem cells (mESC) E14 mESC (E14Tg2a.4) were obtained from Mutant Mouse Regional Resource Centers (015890-USCD). The mESC was cultured on 0.1% gelatin coated plates with Glasgow's MEM supplemented with 1000 U/mL LIF (Millipore, ESG1106), 10% ES-certified FBS (Thermo Fisher 16141061), non-essential amino acids, and L-glutamine. To confirm the identity of the mESC, we performed differentiation assay, confirmed the expected changes in cell morphology, and verified expression of pluripotency and differentiation markers using qRT-PCR, including Nanog, Oct4, Brachyury, Flk1, Myf5, Gata4, Sox17, Pax6, Otx2. We confirmed the purity of the culture by performing mycoplasma testing. 
METHOD DETAILS Xenopus in vitro fertilization
Xenopus in vitro fertilization was performed according to [39] . Testes were isolated from male X. laevis and stored in 1x Marc's Modified Ringer (MMR) with 50 mg/ml gentamicin for up to two weeks. Ovulation was induced in female X. laevis by injection of 600-800U human chorionic gonadotropin (HCG) 14-16 hr prior to egg collection. Eggs were fertilized by incubation in a sperm solution in 0.1xMMR for 30 min. Fertilized eggs were dejellied in 20 mg/ml cysteine, pH 8.0 in 0.1xMMR for 2-5 min. Embryos were reared in 0.1xMMR at 14 C.
DNA constructs 3kb fragment of the siamois promoter [10] was inserted into pGL4.12 (Promega, E6671) using KpnI and BglII. For promoter analysis, the desired length of a promoter fragment was amplified out, and cloned into pGL4.12 using KpnI and BglII. For the rescue experiments, the desired length of a promoter fragment was amplified out with the 11-bp sequence added on the 5 0 end, with 5bp of endogenous sequence 3 0 to the 11-bp NRE included as a spacer. For mutagenesis analysis, single-base mutation was performed on 1.3 kb pSia-luc using QuikChange II (Agilent Technologies, 200523).
Embryo microinjection
Needles for microinjection were made from capillary tubing (Borosil 1.2mm x 0.9mm ID, FHC Inc, 30-31-0) pulled using Flamming/ Brown micropipette puller (Sutter Instrument, P-97). The needle was calibrated to produce a 10 nL ejection volume. Calibrated needles were attached to a microinjector (Warner Instruments, Picoliter Microinjector PLI-100A) and filled with the DNA construct solution. Embryos were collected at 4-cell stage, and placed in 5% Ficoll/0.1xMMR. Each cell in the embryos was injected with 10nl solution on the equator for a total of 4 injections per embryo. Injected embryos were reared in 0.1x MMR.
Lithium treatment
Treatment with lithium chloride (Sigma, L4408) was performed when the embryos were at 32-cell stage, by incubating the embryos for 5 min in 0.1x MMR with 0 mM, 150 mM, or 300 mM LiCl. Embryos were subsequently thoroughly washed, let develop further in 0.1x MMR, and harvested at the appropriate stage for different assays.
Dual luciferase assay
Embryos were injected at 4-cell stage with a total of 100 pg/mL pSia-luc and 25 pg/mL modified pRL-TK (Promega, E2241). The modified pRL-TK has the Rluc gene replaced with the hRlucCP from pGL4.84 (Promega, E7521), which is the destabilized version of Rluc and produces quicker and stronger expression than its stable counterpart. Dual luciferase assay was performed using the Promega system (E1960). Three to four pools of 10 embryos at stage 10 were collected from each sample and lysed in 50 ml of Passive Lysis Buffer. 5-10 mL of cleared lysate was analyzed on a Victor X plate reader (PerkinElmer). For each biological replicate, 2-3 technical replicates were measured. The ratio of firefly to renilla luciferase activity (Luc/Ren ratio) was calculated for each data point, and averaged across the technical replicates.
b-galactosidase assay Xenopus embryos were injected with 3kb or 848bp pSia-LacZ at 4-cell stage, treated with lithium for 5 min at 32-to 64-cell stage, and fixed at stage 10. To visualize the promoter activity, expression of b-galactosidase was detected by x-gal staining following the manufacturer's procedure (Thermo Fisher, K1465-01). 30 embryos/tube were incubated in the fixing buffer for 30 min on a nutator at room temperature, rinsed twice with 1x PBS + 2 mM MgCl 2 , and stained with 0.5 mL of staining buffer at 37 C in the dark until the stain develops. Afterward, the embryos were washed twice with 1x PBS, twice with methanol, and photographed.
Xenopus extract
Xenopus extract preparation was performed according to [40] with modifications. Female X. laevis frogs were injected with 50 units of PMSG 2 days prior and 600-800U HCG 16 hr prior to egg collections. Each frog was placed in a container with 3-4 L of 1xMMR. The next day, eggs were rinsed, examined for quality, and dejellied in 10 mM DTT / 50mM HEPES, pH 8.2. Dejellied eggs were rinsed in Wash Buffer (20 mM HEPES, pH 7.9, 2 mM MgCl2, 0.1 mM EDTA, pH 8, 100 mM KCl), transferred to Extraction Buffer (Wash Buffer, 1mM DTT, 10 mg/mL each of leupeptin, chymostatin and pepstatin A). Eggs were packed by quick centrifugation, the excess liquid removed, and crushed by centrifugation at 10,000 g for 15 min. The crude supernatant was diluted to $10 mg/mL, and then cleared further with centrifugation at 100,000 g for 1 hr. The high speed supernatant was used for EMSA analysis.
Electric Mobility Shift Assay (EMSA) Double stranded DNA probes were synthesized from IDT and labeled at the 5 0 end of one strand with IR680 or IR800 dye. 4 mL of Xenopus egg extract was added to a 20 ml total reaction mixture containing 20 mM HEPES, pH 7.9, 50 mM KCl, 10 mM MgCl 2 , 1 mg/ml poly(dI-dC), 4% Ficoll 400, and incubated for 30 min on ice. 1 ml of labeled probe DNA (50 fmol) was then added, and the reaction was incubated for another 2 hr to overnight on ice. The whole binding reaction was loaded onto a 4% or 6% native DNA retardation gel with 1x TGE buffer (Novex EC6058BOX, Invitrogen). Gels were run at 115 V at 4 C in 1x TGE buffer for 1.75 hr (before the actual run, the gels were pre-run for an hour). For the probe competition assays, the reaction mixture was pre-incubated with unlabeled dsDNA competitors for 30 min, before adding the labeled probe. For the antibody competition assay, specific antibodies were pre-incubated with the reaction mixture for 1.5 hr before addition of the labeled probe. The gel was imaged directly with the LiCOR Odyssey Imager.
Purification of recombinant Xb-catenin and XTcf3
Xb-catenin-His9 or GST-XTCF3-His9 in pETKatN10 were expressed and purified from E. coli BL21 (DE3) (EMD, 69450). For protease inhibitors, we used 1x cOmplete EDTA-free protease inhibitor (Roche, 11873580001). Transformed cells were cultured with shaking at 37 C until OD600 is 0.4, and then chilled on ice for 20 min. Protein expression was induced with 0.4 mM IPTG for 3 hr at 25 C. Cell pellets were suspended in lysis buffer (1x PBS, 500 mM NaCl, 0.5% Triton X-100, 0.1% BSA, 1% glycerol, 5 mM DTT, protease inhibitors) and sonicated 5x10 s at 30% output. Crude cell extracts were centrifuged for 20 min. GST affinity purification: clarified extract was incubated with glutathione Sepharose beads (GE Healthcare, 17-0756-01) for 2.5 hr at 4 C. Beads were washed with wash buffer (1x PBS, 500 mM NaCl, 0.5% Triton X-100, 1% glycerol, 5 mM DTT, protease inhibitors) for 30 min at 4 C. GST-XTCF3-His9 was eluted with elution buffer (20 mM reduced glutathione, 50 mM Tris HCl, pH 9.5, 150 mM NaCl, 1 mM DTT, 0.1% Triton X-100), dialysed against dialysis buffer (50 mM Tris HCl, pH 7.4, 300 mM NaCl, 1 mM DTT, 0.01% Triton X-100) using Slide-A-Lyzer 10,000 MWCO (Thermo Scientific), and concentrated with Vivaspin2 (VIVAproducts). His-tag affinity purification: the partially purified fraction from GST-affinity purification for GST-XTCF3-His9 or bacterial lysate expressing XbÀcatenin-His9 was applied to Ni-NTA column, and incubated with gentle rotation for 3 hr at 4 C. Unbound proteins were removed by gravity-flow and washed 3 times with wash buffer (1x PBS, 20 mM Imidazole, protease inhibitors). Target proteins were eluted with elution buffer (1x PBS, 250 mM Imidazole, pH 7.4) with gentle rotation at 4 C, 30 min, concentrated and buffer changed to 10 mM HEPES-KOH (pH 7.9) with Amicon Ultra-15 10,000 MWCO (EMD Millipore, UFC901008).
Chromatin immunoprecipitation
Xenopus embryos Embryos at stage 10 were fixed and crosslinked with 1% formaldehyde/PBS for 1 hr. Crosslinking was stopped with 125 mM glycine/ PBS. Fixed embryos were transferred to 600 mL of cold RIPA buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.25% Na-Deoxycholate, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 0.5 mM DTT, Roche protease inhibitor cocktail), homogenized with a pestle, and then let sit on ice for 15 min. The chromatin was pelleted at 14,000 g for 10 min at 4 C. The pellet was resuspended in 650 mL of cold RIPA buffer, sonicated for 10 rounds of 20 s bursts with 30% output and 45 s intervals for each round. The supernatant was cleared with 14,000 g for 10 min at 4 C, and incubated with BSA-blocked protein G agarose beads (50 ml) for 2 hr to reduce non-specific binding. The precleared supernatant was incubated with 1 mg of Xb-catenin antibody or control IgG pre-coated protein G beads (50 mL per each condition) overnight at 4 C with mixing. The beads were washed three times each with wash buffer A (20 mM Tris-HCl, pH 8.0, 0.1% SDS, 1% Triton X-100, 2 mM EDTA, 500 mM NaCl) and wash buffer B (10 mM Tris, pH 8.0, 0.25 M LiCl, 1% NP-40, 1% Na-Deoxycholate, 1 mM EDTA). The washed beads were treated with DNase-free RNase A in 10 mM Tris-HCl, pH 8.0 for 1 hr, and then washed twice with 1 mL of TE (10 mM Tris, p8.0, 1 mM EDTA). To elute the immune-complexes, the beads were incubated in 250 mL of TES buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 1% SDS) at 65 C for 10 min with vigorous vortexing every 2 min. Crosslinking was reversed by heating at 65 C overnight with 0.5 mg/ml Proteinase K, 0.1% SDS in PBS. The released DNA was purified and analyzed by PCR. mESC Cells were to grown to 80% confluency on 10 cm plates, crosslinked with 1% formaldehyde/PBS for 10 min at 21 C. Crosslinking was stopped with 125 mM glycine/PBS and washed twice with PBS. Fixed cells were scraped and collected in 1 mL PBS with 10 mL of 100x protease/phosphatase inhibitor cocktail (Thermo Scientific, 1861281). The cells were then centrifuged at 10,000 g for 10 min at 4 C and resulting pellet was frozen at À80 C. Nuclear fraction of the cells was isolated using a hypotonic lysis buffer (10 mM Tris-HCl, pH 7.5, 10 mM NaCl, 3 mM MgCl 2 , 0.3% NP-40, 10% glycerol) [41] . We then proceeded with Chip-IT kit (Active Motif, 53040), with the given protocol except that we used Dynabeads Protein G (Thermo Fisher, 10003D). Sonication performed at 40 cycles of 0.7 s on / 3.3 s off at 20% amplitude using Branson SFX 250 Sonicator to break down chromosomes into 0.1 -0.3 kb fragments. For pulldowns, we used mouse b-catenin antibody (BD Transduction Laboratories, 610153) and normal mouse IgG (Millipore, 12-371B) as a control.
CRISPR/Cas9 transfection in mESC
We obtained PX330 generously donated to Addgene by the Feng Zhang lab [35] . Into the PX330 plasmid, we inserted gRNA sequence targeting the T promoter, removed the Cas9 coding cassette, and inserted neomycin resistance cassette. To synthesize the donor plasmid for TD11-bp clones in mESCs, we used genomic prep of the cells to clone out 5 0 and 3 0 homologous arms in the T promoter. Another insert fragment was cloned from the genomic prep that included deleted 11-bp regions. The three fragments were integrated into a generic plasmid backbone using Gibson assembly (New England Biolabs, E2611S).
For transfection, 2.5 3 10 5 mESCs were plated on 24 wells and grown overnight. We used 400 ng of the modified PX330 plasmid, 150 ng of donor plasmid, 12 pmol Cas9 recombinant protein (IDT, 1074182) in Lipofectamine LTX with PLUS (Thermo Fisher, 15338100). The cells were transfected for 24 hr, transiently selected with neomycin for 5 days, dissociated into single cells, and grown as single clones.
